Exhibit 23.2
Consent of Independent Auditors
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated September 27, 2012 (except Note 16 as to which the date is August 11, 2014) with respect to the financial statements of Trillium Therapeutics Inc. in the Amendment No. 2 to the Registration Statement on Form F-1 for the registration of common shares and Series II Non-Voting Convertible First Preferred Shares of Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.).
/s/ Ernst & Young LLP | ||
Toronto, Canada | Chartered Professional Accountants | |
March 30, 2015 | Licensed Public Accountants |